INCOME STATEMENT
Piramal Pharma Ltd.
BSE
Jun 06, 04:01
206.40
-1.70 ( -0.82%)
Volume
177854
Prev. Close
208.10
Open Price
208.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06, 03:59
206.33
-1.75 ( -0.84%)
Volume
2940969
Prev. Close
208.08
Open Price
208.08
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE0DK501011
|
Market Cap. ( ₹ in Cr. )
|
27426.38
|
P/BV
|
3.47
|
Book Value ( ₹ )
|
59.53
|
|
BSE Code
|
543635
|
52 Week High/Low ( ₹ )
|
308/141
|
FV/ML
|
10/1
|
P/E(X)
|
301.21
|
|
NSE Code
|
PPLPHARMAEQ
|
Book Closure
|
12/07/2024
|
EPS ( ₹ )
|
0.69
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 13 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 5285.71 | 4325.31 | 3349.59 | 2977.57 | 2899.75 |
| Other Operating Revenues | 0.00 | 64.80 | 93.63 | 117.38 | 39.06 |
| Total Operating Revenues | 5285.71 | 4390.11 | 3443.22 | 3094.95 | 2938.81 |
| | | | | | |
| Other Income | 207.35 | 202.06 | 341.07 | 223.59 | 197.97 |
| Total Revenue | 5493.06 | 4592.17 | 3784.29 | 3318.54 | 3136.78 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1596.93 | 1545.55 | 1166.48 | 1003.68 | 986.70 |
| Purchase Of Stock-In Trade | 733.60 | 624.91 | 548.69 | 509.70 | 183.21 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -84.57 | -61.62 | 53.31 | -30.17 | 57.86 |
| Employee Benefit Expenses | 736.19 | 613.93 | 548.50 | 425.30 | 395.15 |
| Finance Costs | 114.56 | 107.10 | 115.87 | 53.55 | 4.71 |
| Depreciation And Amortisation Expenses | 222.09 | 205.26 | 192.08 | 130.64 | 143.64 |
| Other Expenses | 1263.12 | 1049.42 | 1028.71 | 789.14 | 696.96 |
| Total Expenses | 4581.92 | 4084.55 | 3653.64 | 2881.84 | 2468.23 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 911.14 | 507.62 | 130.65 | 436.70 | 668.55 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | -6.96 | -12.47 | 18.23 |
| Profit/Loss Before Tax | 911.14 | 507.62 | 123.69 | 424.23 | 686.78 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 219.74 | 112.48 | 38.77 | 96.34 | 104.98 |
| Deferred Tax | 0.00 | 3.92 | 15.42 | -15.16 | 10.30 |
| Total Tax Expenses | 219.74 | 116.40 | 54.19 | 81.18 | 115.28 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 691.40 | 391.22 | 69.50 | 343.05 | 571.50 |
| | | | | | |
| Profit/Loss From Continuing Operations | 691.40 | 391.22 | 69.50 | 343.05 | 571.50 |
| | | | | | |
| Profit/Loss For The Period | 691.40 | 391.22 | 69.50 | 343.05 | 571.50 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 5.22 | 3.05 | 0.58 | 2.91 | 9.11 |
| Diluted EPS (Rs.) | 5.20 | 3.05 | 0.58 | 2.91 | 9.11 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Dividend Rate (%) | 1.40 | 1.10 | 0.00 | 0.00 | 0.00 |